GlucoTrack Stock Falls on Plans to Sell $3M Note

Dow Jones
09/13
 

By Katherine Hamilton

 

GlucoTrack shares fell after the company said it issued a $3.6 million convertible promissory note for $3 million.

The stock fell 8% to $9.75 in after-hours trading on Friday. At the close, it was down 98% this year.

The medical technology company said the note bears no interest and has an original issue discount of $600,000. It is an unsecured obligation and will rank equal in right of payment with GlucoTrack's existing and future unsecured debt.

The note will be due and payable 12 months after the issue date.

On Thursday, GlucoTrack entered into a purchase agreement with Sixth Borough Capital Fund establishing an equity line of credit. GlucoTrack has the right to sell Sixth Borough, and Sixth Borough is obligated to purchase up to $20 million of GlucoTrack's shares. GlucoTrack is required to use all of the proceeds from that sale to pay back the note.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

September 12, 2025 18:26 ET (22:26 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10